NCT05759208Phase 2Completed

The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease

Study sponsor: Okyo Pharma Ltd · OKYO

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2023-12-15Actual
Enrollment · participants240Actual
Source updated2024-02-09Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.